Pulmonx Corporation (LUNG) Tops Q2 EPS by 3c

Pulmonx Corporation (NASDAQ: LUNG) reported Q2 EPS of ($0.39), $0.03 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $20.8 million versus the consensus estimate of $20.15 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• FTI Consulting names Dean Felton as Senior Managing Director in Australia
• W. P. Carey prices $350 million in senior notes due 2036